CAS Registry Numbers

Agreement reached

Elsevier and CAS recently reached agreement to increase cooperation in information exchange, which will improve their respective operations and service offerings. Under that agreement, Elsevier is providing enhanced electronic versions of its journal articles to CAS, and CAS in turn is helping Elsevier identify additional CAS Registry Numbers in certain of its databases. The CAS Registry Number® identification aspect of the agreement is being carried out periodically through an automated, first level, “machine comparison”. That method is neither comprehensive nor detailed relative to many chemical structure conventions, and so this resulting addition of Registry numbers does not represent a complete comparison of Elsevier resources with the CAS Registry, the most comprehensive substance collection. Nonetheless, we anticipate these added CAS Registry Numbers will be useful and helpful for search and identification of more Elsevier database substances. From time to time more CAS Registry Numbers will be added.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).